RPG Life Sciences Q2 Revenue Rises 16.5% to Rs 211.6 Crore
Revenue from operations rose 16.5% year on year in the second quarter of FY27. The company said domestic formulations outperformed the Indian pharmaceutical market.
Adjusted EBITDA grows 15 per cent to Rs 50.1 crore as domestic formulations business outperforms the Indian pharmaceutical marketRPG Life Sciences reported a 16.5 per cent year-on-year increase in revenue from operations to Rs 211.6 crore in the second quarter of FY27, crossing the Rs 200-crore qua…